Trial Profile
A Study to Evaluate the Clinical and Economic Outcomes of Methicillin-resistant Staphylococcus aureus (MRSA) Pneumonia Patients Treated With Linezolid or Vancomycin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Vancomycin (Primary)
- Indications Pneumonia
- Focus Therapeutic Use
- 28 Jun 2016 New trial record
- 12 May 2016 Results published in the Pharmacotherapy